POSTMARKETING SURVEILLANCE OF ABUSE LIABILITY OF SIBUTRAMINE
Bewaard in:
ARFKEN, C.L., ET AL., POSTMARKETING SURVEILLANCE OF ABUSE LIABILITY OF SIBUTRAMINE. DRUG AND ALCOHOL DEPENDENCE, Vol. 69, no. 2 (2003), p. 169-173.
Ref.
119272
Plaats:
SIIS R.854 Archivo
Palabras clave:
Consumo, Control, Drogodependencias, Fármacos, EE.UU.
Consumo, Control, Drogodependencias, Fármacos, EE.UU.
Gelijkaardige items: POSTMARKETING SURVEILLANCE OF ABUSE LIABILITY OF SIBUTRAMINE
- Slow release oral morphine sulfate abuse: results of the postmarketing surveillance systems for psychoactive prescription drug abuse in France
- ABUSE LIABILITY ASSESSMENT OF CNS DRUGS
- DRUG FORMULATION AND ABUSE LIABILITY
- PERFORMANCE AND PHYSIOLOGICAL MEASURES IN ABUSE LIABILITY EVALUATION
- PREFERENCE PROCEDURES FOR TESTING THE ABUSE LIABILITY OF DRUGS IN HUMANS
- ABUSE LIABILITY OF BARBITURATES AND OTHER SEDATIVE-HYPNOTICS